...
首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >The clinical usefulness of glucose tolerance testing in gestational diabetes to predict early postpartum diabetes mellitus.
【24h】

The clinical usefulness of glucose tolerance testing in gestational diabetes to predict early postpartum diabetes mellitus.

机译:葡萄糖耐量测试在妊娠糖尿病中预测早期产后糖尿病的临床实用性。

获取原文
获取原文并翻译 | 示例
           

摘要

We examined the clinical usefulness of antepartum clinical characteristics, along with measures of glucose tolerance, in Dutch multiethnic women with gestational diabetes mellitus (GDM) for their ability to predict type 2 diabetes within 6 months of delivery (early postpartum diabetes). The present study comprised a cross-sectional 5-year investigation (1998-2003) of a consecutive series of 168 women with GDM identified by a two-stage protocol at 16-33 weeks of gestation. The following data were collected for all women: age and gestational age at entry into the study; prepregnancy body mass index (BMI); ethnicity; obstetric and clinical history, including the onset of early postpartum diabetes; pregnancy outcome; level of fasting C-peptide; and glycemic parameters of 50-g 1-h glucose challenge test and 100-g 3-h oral glucose tolerance test (diagnostic OGTT). We used receiver operating characteristic (ROC) curve analysis to test the clinical usefulness of the glycemic parameters. A total of 11 women (6.5%) developed early postpartum diabetes. Apart from family history of diabetes (p = 0.052), anthropometric, maternal, and neonatal clinical parameters showed no association with early postpartum diabetes in univariate analyses. The level of fasting glucose, and both the glucose challenge test and diagnostic OGTT post-load glucose levels and glucose areas were associated with early postpartum diabetes. ROC curve analysis identifiedall three glucose challenge-test parameters, including fasting glucose concentration, as poor diagnostic tests, with a positive predictive value of approximately 22%, whereas the positive predictive value associated with the area under the diagnostic OGTT curve increased progressively over monitoring time from 20.6% to 100%. Using a 3-h OGTT glucose area threshold of 35.7 mmol.h/L resulted in 100% sensitivity and 100% specificity, identifying the 11 women who developed early postpartum diabetes. In summary, we can conclude from the present analysis that early postpartum diabetes is rare in GDM women (6.5%), and that the clinical usefulness of the total area under the diagnostic 3-h OGTT is superior to all other glycemic parameters for detecting early postpartum diabetes.
机译:我们检查了荷兰多族裔妊娠糖尿病(GDM)妇女在分娩后6个月内预测2型糖尿病的能力(产后早期),探讨了产前临床特征的临床有用性以及葡萄糖耐量的测量方法。本研究包括横断面5年调查(1998-2003年),该研究连续两个系列,在妊娠16-33周时通过两阶段方案确定了168名GDM妇女。收集了所有妇女的以下数据:进入研究的年龄和胎龄;孕前体重指数(BMI);种族;产科和临床病史,包括早期产后糖尿病的发作;怀孕结果;空腹C肽水平; 50 g 1-h葡萄糖激发试验和100 g 3-h口服葡萄糖耐量试验(诊断性OGTT)的血糖参数。我们使用接收器工作特征(ROC)曲线分析来测试血糖参数的临床实用性。共有11名妇女(6.5%)患有早期的产后糖尿病。除了糖尿病家族史(p = 0.052),在单因素分析中,人体测量,孕妇和新生儿的临床参数均与早期产后糖尿病无关。空腹血糖水平,葡萄糖激发试验和诊断性OGTT负荷后血糖水平以及血糖面积均与早期产后糖尿病有关。 ROC曲线分析将包括空腹血糖浓度在内的所有三个葡萄糖挑战测试参数确定为差的诊断测试,其阳性预测值约为22%,而与诊断性OGTT曲线下面积相关的阳性预测值在监测时间内逐渐增加从20.6%到100%使用35.7小时的OGTT葡萄糖面积阈值35.7 mmol.h / L可获得100%的敏感性和100%的特异性,从而鉴定出11名发展为早期产后糖尿病的女性。总而言之,我们可以从目前的分析中得出结论,GDM妇女很少发生早期产后糖尿病(6.5%),并且诊断3-h OGTT的总面积的临床实用性优于所有其他血糖参数来检测早期产后糖尿病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号